Presentations at the American Association of Cancer Research Virtual Conference created some volatility. Verastem Inc VSTM 7.41% became a casualty of “not-so-impressive” clinical data on its Phase 1 asset VS-6766 that targets KRAS mutant advanced solid tumors. The stock shed about 57% to a low of $1.77 before recovering some lost ground.
Here are the key catalysts for the unfolding week.
Conferences
SunTrust Robinson Humphrey 6th Annual Life Sciences Summit (Virtual Conference): May 5–6Maxim Group M-Vest Infectious Disease Virtual Conference: May 5
Clinical Readouts
Adverum Biotechnologies Inc ADVM 1.27% is scheduled to present new data from the OPTIC Phase1 clinical trial of ADVM-022 intravitreal gene therapy in wet age-related macular degeneration. The call discussing the results is scheduled for Monday afternoon.Auris Medical Holding Ltd EARS 4.34% is due to release top-line data from the completed Phase 1b AM-201 trial in early May. AM-201 is being evaluated in antipsychotic-induced weight gain.
Early Q2 Schedule
Ovid Therapeutics Inc OVID 8.79%: Phase 2 top-line data for OV101 in Fragile X syndrome
Iterum Therapeutics PLC ITRM 5.37%: Phase 3 data for Sulopenem in uncomplicated and complicated urinary tract infections
Enanta Pharmaceuticals Inc ENTA 2.39%: data from our INTREPID study of EDP-305 in patients with primary biliary cholangitis
Earnings
Monday• Marinus Pharmaceuticals Inc MRNS 1.96% (before the market open)
• Minerva Neurosciences Inc NERV 4.68% (before the market open)
• Epizyme Inc EPZM 4.31% (before the market open)
• SI-Bone Inc SIBN 3.4% (after the market close)
• Corcept Therapeutics Incorporated CORT 3.63% (after the market close)
• Chembio Diagnostics Inc CEMI (after the market close)
• GenMark Diagnostics, Inc GNMK 0.72% (after the market close)
• Kura Oncology Inc KURA 4.6% (after the market close)
• Varian Medical Systems, Inc. VAR 2.54% (after the market close)
• Fulgent Genetics Inc FLGT 5.95% (after the market close)
Tuesday
• Oxford Immunotec Global PLC OXFD 3.29% (before the market open)
• Karyopharm Therapeutics Inc KPTI 12.29% (before the market open)
• Haemonetics Corporation HAE 2.52% (before the market open)
• Antares Pharma Inc ATRS 0.62% (before the market open)
• Harvard Bioscience, Inc. HBIO 5.09% (before the market open)
• Vericel Corp VCEL 3.38% (before the market open)
• Regeneron Pharmaceuticals Inc REGN 0.07% (before the market open)
• Neuronetics Inc STIM 8.4% (before the market open)
• Mallinckrodt PLC MNK 17.49% (before the market open)
• Akebia Therapeutics Inc AKBA 1.48% (before the market open)
• Agile Therapeutics Inc AGRX 14.23% (after the market close)
• Aquestive Therapeutics Inc AQST 3.25% (after the market close)
• Akcea Therapeutics Inc AKCA 11.31% (after the market close)
• Acorda Therapeutics Inc ACOR 7.28% (after the market close)
• Axonics Modulation Technologies Inc AXNX 3.31% (after the market close)
• Synthetic Biologics Inc SYN 3.65% (after the market close)
• T2 Biosystems Inc TTOO 1.12% (after the market close)
• Iovance Biotherapeutics Inc IOVA 0.47% (after the market close)
• MacroGenics Inc MGNX 7.22% (after the market close)
• Zogenix, Inc. ZGNX 5.74% (after the market close)
• Jazz Pharmaceuticals PLC JAZZ 0.6% (after the market close)
• Exelixis, Inc. EXEL 2.41% (after the market close)
• Myriad Genetics, Inc. MYGN 4.27% (after the market close)
• Inspire Medical Systems Inc INSP 4.26% (after the market close)
• Rigel Pharmaceuticals, Inc. RIGL 4.47% (after the market close)
• Supernus Pharmaceuticals Inc SUPN 0.77% (after the market close)
• Nevro Corp NVRO 5.42% (after the market close)
• Clovis Oncology Inc CLVS 5.91% (after the market close)
• InVitae Corp NVTA 9.16% (after the market close)
• Cytosorbents Corp CTSO 0.47% (after the market close)
• Cardiovascular Systems Inc CSII 4.05% (after the market close)
• Cerus Corporation CERS 8.62% (after the market close)
• Deciphera Pharmaceuticals Inc DCPH 9.68% (after the market close)
• Incyte Corporation INCY 0.37% (after the market close)
• Orthopediatrics Corp KIDS 8.97% (after the market close)
Wednesday
• Eyepoint Pharmaceuticals Inc EYPT 2.56% (before the market open)
• Horizon Therapeutics PLC HZNP 1.17% (before the market open)
• Constellation Pharmaceuticals Inc CNST 0.64% (before the market open)
• Alnylam Pharmaceuticals, Inc. ALNY 2.07% (before the market open)
• IVERIC bio Inc ISEE 6.7% (before the market open)
• Blueprint Medicines Corp BPMC 2.86% (before the market open)
• BioCryst Pharmaceuticals, Inc. BCRX 9.46% (before the market open)
• Strongbridge Biopharma plc SBBP 7.69% (before the market open)
• Evofem Biosciences, Inc. EVFM 5.49% (before the market open)
• Neurocrine Biosciences, Inc. NBIX 2.6% (before the market open)
• Jounce Therapeutics Inc JNCE 0.61% (before the market open)
• PPD Inc PPD 4.94% (before the market open)
• Zoetis Inc ZTS 1.19% (before the market open)
• Ionis Pharmaceuticals Inc IONS 0.38% (before the market open)
• TherapeuticsMD Inc TXMD 12.66% (before the market open)
• Avanos Medical Inc AVNS 0.13% (before the market open)
• Aerie Pharmaceuticals Inc AERI 6.17% (after the close)
• Allogene Therapeutics Inc ALLO 1.56% (after the close)
• ADMA Biologics Inc ADMA 2.03% (after the close)
• Alexion Pharmaceuticals, Inc. ALXN 3.31% (after the close)
• AxoGen, Inc Common Stock AXGN 0.92% (after the close)
• Global Blood Therapeutics Inc GBT 2.91% (after the close)
• Pacific Biosciences of California PACB 1.36% (after the close)
• Theravance Biopharma Inc TBPH 8.26% (after the close)
• BioTelemetry Inc BEAT 2.57% (after the close)
• Bio-Rad Laboratories, Inc. BIO 1.52% (after the close)
• Veracyte Inc VCYT 2.97% (after the close)
• Ligand Pharmaceuticals Inc. LGND 5.65% (after the close)
• Precigen Inc PGEN 11.67% (after the close)
• Ironwood Pharmaceuticals, Inc. IRWD 3.6% (after the close)
• OraSure Technologies, Inc. OSUR 5.65% (after the close)
• NuVasive, Inc. NUVA 3.84% (after the close)
• Sarepta Therapeutics Inc SRPT 3.85% (after the close)
• Natera Inc NTRA 5.32% (after the close)
• Vanda Pharmaceuticals Inc. VNDA 1.3% (after the close)
• Qiagen NV QGEN 0.06% (after the close)
• Enanta Pharmaceuticals Inc ENTA 2.39% (after the close)
• Esperion Therapeutics Inc ESPR 5.43% (after the close)
• G1 Therapeutics Inc GTHX 6.32% (after the close)
• Quidel Corporation QDEL 0.17% (after the close)
• Cytokinetics, Inc. CYTK 4.1% (after the close)
• MannKind Corporation MNKD 3.85% (after the close)
Thursday
• Integra Lifesciences Holdings Corp IART 0.47% (before the market open)
• Intra-Cellular Therapies Inc ITCI 5.15% (before the market open)
• Endo International PLC ENDP 3.7% (before the market open)
• Xeris Pharmaceuticals Inc XERS 9.44% (before the market open)
• Moderna Inc MRNA 4.22% (before the market open)
• Syros Pharmaceuticals Inc SYRS 0.24% (before the market open)
• Elanco Animal Health Inc ELAN 2.75% (before the market open)
• Athenex Inc ATNX 3.36% (before the market open)
• Aldeyra Therapeutics Inc ALDX 11.43% (before the market open)
• Albireo Pharma Inc ALBO 5.03% (before the market open)
• ANI Pharmaceuticals Inc ANIP 3.05% (before the market open)
• Agenus Inc AGEN 7.69% (before the market open)
• Amicus Therapeutics, Inc. FOLD 4.32% (before the market open)
• Brainstorm Cell Therapeutics Inc BCLI 1.79% (before the market open)
• Bristol-Myers Squibb Co BMY 1.33% (before the market open)
• Progenics Pharmaceuticals, Inc. PGNX 6.6% (before the market open)
• X4 Pharmaceuticals Inc XFOR 4.83% (before the market open)
• Miragen Therapeutics Inc MGEN 3.28% (before the market open)
• Kala Pharmaceuticals Inc KALA 3.31% (before the market open)
• Seres Therapeutics Inc MCRB 4.89% (before the market open)
• Intellia Therapeutics Inc NTLA 6.31% (before the market open)
• Momenta Pharmaceuticals, Inc. MNTA 5.39% (before the market open)
• Editas Medicine Inc EDIT 3.98% (before the market open)
• Pacira Biosciences Inc PCRX 6.68% (before the market open)
• Syndax Pharmaceuticals Inc SNDX 0.89% (after the close)
• Tricida Inc TCDA 6.08% (after the close)
• Helius Medical Technologies Inc HSDT 11.87% (after the close)
• Twist Bioscience Corp TWST 4.49% (after the close)
• Athersys Inc ATHX 6.52% (after the close)
• Accelerate Diagnostics Inc AXDX 5.41% (after the close)
• Adamas Pharmaceuticals Inc ADMS 1.55% (after the close)
• Arena Pharmaceuticals, Inc. ARNA 2.94% (after the close)
• Anika Therapeutics Inc ANIK 2.77% (after the close)
• Arrowhead Pharmaceuticals Inc ARWR 5.43% (after the close)
• ACADIA Pharmaceuticals Inc. ACAD 7% (after the close)
• Calithera Biosciences Inc CALA 4.73% (after the close)
• BioDelivery Sciences International, Inc. BDSI 2.63% (after the close)
• Puma Biotechnology Inc PBYI 5.67% (after the close)
• Coherus Biosciences Inc CHRS 3.43% (after the close)
• Kindred Biosciences Inc KIN 3.39% (after the close)
• PDL BioPharma Inc PDLI 0.88% (after the close)
• Rockwell Medical Inc RMTI 7.3% (after the close)
• Penumbra Inc PEN 3.5% (after the close)
• Pfenex Inc PFNX 5.76% (after the close)
• ZIOPHARM Oncology Inc. ZIOP 9.29% (after the close)
• NovaBay Pharmaceuticals, Inc. NBY 2.57% (after the close)
• ICU Medical Inc ICUI 0.68% (after the close)
• Nektar Therapeutics NKTR 5.96% (after the close)
• Savara Inc SVRA 4.56% (after the close)
• Sunesis Pharmaceuticals, Inc. SNSS 10.38% (after the close)
• OptiNose Inc OPTN 3.47% (after the close)
• Eloxx Pharmaceuticals Inc ELOX 4.79% (after the close)
• Five Prime Therapeutics Inc FPRX 11.59% (after the close)
• Flexion Therapeutics Inc FLXN 9.77% (after the close)
• FibroGen Inc FGEN 5.18% (after the close)
• Globus Medical Inc GMED 3.92% (after the close)
• Guardant Health Inc GH 4.52% (after the close)
• OpGen Inc OPGN 3.06% (after the close)
• Lineage Cell Therapeutics Inc LCTX 5.27% (after the close)
• Dynavax Technologies Corporation DVAX 1.18% (after the close)
• Chiasma Inc CHMA 3.87% (after the close)
• Collegium Pharmaceutical Inc COLL 10.98% (after the close)
• Dicerna Pharmaceuticals Inc DRNA 1.17% (after the close)
• Caladrius Biosciences Inc CLBS 16.36% (after the close)
• Glaukos Corp GKOS 1.08% (after the close)
• Celcuity Inc CELC 7.99% (after the close)
• Codexis, Inc. CDXS 5.08% (after the close)
• CytomX Therapeutics Inc CTMX 8.62% (after the close)
• Insulet Corporation PODD 2.42% (after the close)
Friday
• Meridian Bioscience, Inc. VIVO 1.17% (before the market open)
• Mersana Therapeutics Inc MRSN 8.86% (before the market open)
• Ocular Therapeutix Inc OCUL 0.17% (before the market open)
https://www.benzinga.com/general/biotech/20/05/15926105/the-week-ahead-in-biotech-smid-cap-earnings-news-flow-picks-up-pace
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.